Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-19T07:28:15.308Z Has data issue: false hasContentIssue false
  • English
  • Français

Buspirone: A Worldwide Update

Published online by Cambridge University Press:  06 August 2018

M. J. Napoliello  and
A. G. Domantay
M. J. Napoliello
Affiliation:
Central Nervous System Medical Planning, Bristol-Myers Squibb Company, and Cornell University Medical College
A. G. Domantay*
Affiliation:
Central Nervous System Medical Planning, Bristol-Myers Squibb Company, P O Box 4000, Princeton, NJ 08543-4000, USA
*
Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

Buspirone is an anxiolytic drug from the azapirone family of molecules. It differs chemically and pharmacologically from the benzodiazepines. Although its profile of efficacy is comparable with that of benzodiazepines, it produces less drowsiness, less psychomotor impairment, less alcohol potentiation, and has less potential for addiction or abuse. Buspirone also appears to have efficacy in major depressive disorders, in comparison with placebo, but its activity in panic disorders is less impressive. It may diminish alcohol dependence both in animals and in chronic alcoholics. Clinical studies in the elderly show no important difference from younger patients in safety and efficacy profile, pharmacokinetics, and dosage requirement. The drug appears to be well tolerated in primary care settings and to be free of adverse clinical interactions with many drugs that might be used concomitantly. However, because its pharmacology differs from that of conventional anxiolytics, patients need to be informed about both its gradual onset of action and absence of euphoria and immediate sedation.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 159 , Issue S12: Anxiety and Serotonin , September 1991 , pp. 40 - 44
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ancoli-Israel, S., Kripke, D. F., Mason, W., et al (1985) Sleep apnea and periodic movements in an aging sample. Journal of Gerontology, 40, 419–425.CrossRefGoogle Scholar
Balster, R. L. & Woolverton, W. L. (1982) Intravenous buspirone self-administration in rhesus monkeys. Journal of Clinical Psychiatry, 43, 34–37.Google ScholarPubMed
Bruno, F. (1989) Buspirone in the treatment of alcoholic patients. Psychopathology, 22 (suppl. ), 49–59.CrossRefGoogle ScholarPubMed
Cassano, G. B., Guerani, G., McNair, D., et al (1989) Generalized anxiety disorder: delimitation and therapeutic approach. Psychiatry Today: Accomplishments and Promises, VIII World Congress of Psychiatry, abstract 1159. Amsterdam: Elsevier.Google Scholar
Colenda, C. C. (1988) Buspirone in treatment of agitated demented patient. Lancet, i, 1169.CrossRefGoogle Scholar
Collins, D. M. & Myers, R. D. (1987) Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol, 4, 49–56.CrossRefGoogle ScholarPubMed
Dement, W. & Guilleminault, C. (1978) Sleep Apnea Syndromes. New York: Alan R. Liss.Google Scholar
De Roeck, J., Cluydts, R., Schotte, C., et al (1989) Explorative single-blind study on the sedative and hypnotic effects of buspirone in anxiety patients. Acta Psychiatrica Scandinavica, 79, 129–135.CrossRefGoogle ScholarPubMed
Erwin, C. N., Linnoila, M., Hartwell, J., et al (1986) Effects of buspirone and diazepam alone and in combination with alcohol on skilled performance and evoked potentials. Journal of Clinical Psychopharmacology, 6, 199–209.CrossRefGoogle ScholarPubMed
Feighner, J. P. & Boyer, W. F. (1988) Serotonin-la agonists. An overview of anxiolytic activity. Psychopharmacology, 96 (suppl. ), abstract WE 05:03.Google Scholar
Fontaine, R., Beaudry, P., Beauclair, L., et al (1987) Comparison of withdrawal of buspirone and diazepam: a placebo controlled study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 11, 189–197.CrossRefGoogle ScholarPubMed
Gammans, R. E., Westrick, M. L., Shea, J. P., et al (1989) Pharmacokinetics of buspirone and elderly patients. Journal of Clinical Pharmacology, 29, 72–78.CrossRefGoogle Scholar
Garner, J. S., Eldridge, F. L., Wagner, P. G., et al (1989) Buspirone, an anxioloytic drug that stimulates respiration. American Review of Respiratory Diseases, 139, 946–950.CrossRefGoogle Scholar
Gastfriend, D. R. & Rosenbaum, J. F. (1989) Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. American Journal of Psychiatry, 146, 914–916.Google ScholarPubMed
Gerhardt, G. (1985) Controlled anxiolytic without evidence of development of dependence. Therapiewoche, 35, 5350–5351.Google Scholar
Goldberg, H. & Finnerty, R. (1982) Comparison of buspirone in two separate studies. Journal of Clinical Psychiatry, 43, 87–91.Google ScholarPubMed
Griffith, J. D., Jasinski, D. R. & Casten, G. P. (1986) Investigation of the abuse liability of buspirone in alcohol-dependent patients. Journal of the American Medical Association, 80 (suppl. 3B ), 30–35.CrossRefGoogle ScholarPubMed
Hammerstad, J., Carter, J., Nutt, J., et al (1986) Buspirone in Parkinson's disease. Clinical Neuropharmacology, 9, 556–560.CrossRefGoogle ScholarPubMed
Hippius, H. (1984) Buspirone workshop. Materia Medica, 81.Google Scholar
Johnstone, E. C., Owens, D. G., Firth, C. D., et al (1980) Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychological Medicine, 10, 321–328.CrossRefGoogle ScholarPubMed
Levine, A. (1988) Buspirone and agitation in head injury. Brain Injury, 2, 165–167.CrossRefGoogle ScholarPubMed
Levine, S. & Napoliello, M.J. (1989) An open study of buspirone in octogenarians with anxiety. Human Psychopharmacology, 4, 51–53.CrossRefGoogle Scholar
Mattila, M., Seppala, T. & Matilla, M. J. (1986) Combined effects of buspirone and diazepam on objective and subjective tests of performance in healthy volunteers. Clinical Pharmacology Therapeutics, 40, 620–626.CrossRefGoogle ScholarPubMed
McMillen, B. A., Scott, S. M. & Davanzo, E. A. (1988) Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs. Journal of Pharmacy and Pharmacology, 40, 885–887.CrossRefGoogle ScholarPubMed
Moring, J., Alarotu, P., Haukijarvi, A., et al (1989) Buspirone vs. diazepam in treatment of anxiety in general practice. Psychiatry Today: Accomplishments and Promises. World Congress of Psychiatry, abstract 1011. Amsterdam: Elsevier.Google Scholar
Moskowitz, H. & Smiley, A. (1982) Effects of chronically administered buspirone and diazepam on driving-related skills of performance. Journal of Clinical Psychiatry, 43, 45–55.Google ScholarPubMed
Napoliello, M. J. & Domantay, A. G. (1988) Newer clinical studies with buspirone. In Buspirone: A New Introduction to the Treatment of Anxiety. International Congress Symposium Services, 133, 59–69.Google Scholar
Newton, R. E., Marunycz, J. D., Alderdice, M. T., et al (1986) Review of the side effect profile of buspirone. American Journal of Medicine, 80, 17–21.CrossRefGoogle ScholarPubMed
Pato, M. T., Pigott, T. A., Hill, J. L., et al (1989) Clomipramine versus buspirone in OCD: a controlled trial. American Psychiatric Association Meeting, 34, abstract NR 14. Washington, DC: APA.Google Scholar
Physician's Desk Reference (1990) Physician's Desk Reference. Oradell, NJ: Medical Economics Co.Google Scholar
Rapoport, D. (1989) Anxiolytic therapy with respiratory implications. Family Practice Recertification, 11, 32–37.Google Scholar
Riblet, L., Eison, A., Eison, M., et al (1984) Neuropharmacology of buspirone. Psychopathology, 17 (suppl. 3 ), 69–78.CrossRefGoogle ScholarPubMed
Rickels, K., Weisman, K., Norstad, N., et al (1982) Buspirone and diazepam in anxiety: a controlled study. Journal of Clinical Psychiatry, 43, 81–86.Google ScholarPubMed
Rickels, K., Schweizer, E., Csanalosi, I., et al (1988) Long term treatment of anxiety and risk of withdrawal. Archives of General Psychiatry, 45, 440–450.CrossRefGoogle ScholarPubMed
Robinson, D. (1985) Buspirone: Long Term Therapy in Anxiety Disorders: An International Update, pp. 93–99. New York: Academy Professional Information Services.Google Scholar
Robinson, D., Napoliello, M. J. & Schenck, J. (1988) The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients. Clinical Therapeutics, 10, 740–746.Google ScholarPubMed
Robinson, D., Shrotriya, R. C., Alms, D., et al (1989) Treatment of panic disorder: nonbenzodiazepine anxiolytics, including buspirone. Psychopharmacy Bulletin, 25, 21–26.Google ScholarPubMed
Sathananthan, G. L., Sanghvi, I., Phillips, N., et al (1975) MJ9022: correlation between neuroleptic potential and stereotypy. Current Therapeutic Research, 18 (no. 5 ), 701–705.Google ScholarPubMed
Schaffler, K. (1986) Psychomotor profile of buspirone. In Recent Advances in Drug Treatment in Psychiatry, pp. 33–40. New York: Academy Professional Information Services.Google Scholar
Schweizer, E., Rickels, K. & Lucki, I. (1986) Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. New England Journal of Medicine, 314, 719–720.Google Scholar
Seidel, W. F., Cohen, S. A., Bliwise, N. G., et al (1985) Buspirone: an anxiolytic without sedative effect. Psychopharmacology, 87, 371–373.CrossRefGoogle ScholarPubMed
Seppala, T., Aranko, K., Mattila, M. J., et al (1982) Effects of alcohol on buspirone and lorazepam actions. Clinical Pharmacology and Therapeutics, 32, 201–207.CrossRefGoogle ScholarPubMed
Sussman, N. (1987) Treatment of anxiety with buspirone. Psychiatrie Annals, 17, 114–118.CrossRefGoogle Scholar
Tiller, J. W. G., Davis, J. A. & Shaw, J. M. (1988) Short-term buspirone treatment in disinhibition with dementia. Lancet, ii, 510.CrossRefGoogle Scholar
Volkerts, E. R., Brookhuis, K. A. & O'Hanlon, J. F. (1987) Effects of treatment with buspirone, diazepam and lorazepam. In Alcohol, Drugs and Traffic Safety, vol. 421 (eds Mordrij, P. & Rossback, T.), pp. 217–222. Amsterdam: Excerpta Medica International Congress Series.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.